# Notice of Intent To Grant Exclusive Patent License; American BioHealth Group, LLC
**AGENCY:**
Department of the Navy, DOD
**ACTION:**
Notice.
**SUMMARY:**
The Department of the Navy hereby gives notice of its intent to grant to American BioHealth Group, LLC, a revocable, nonassignable, exclusive license in the United States to practice, with right to sublicense, the Government-owned invention described in U.S. Patent Application Serial No. 09/766, 625, entitled “Prevention or Reversal of Sensorial Hearing Loss Through Biological Mechanisms,” filed January 23, 2001.
**DATES:**
Anyone wishing to object to the granting of this license has (15) days from the date of this notice to file written objections along with supporting evidence, if any.
**ADDRESSES:**
Written objections are to be filed with the Office of Technology Transfer, Naval Medical Research Center, 503 Robert Grant Ave, Silver Spring, MD 20910-7500.
**FOR FURTHER INFORMATION CONTACT:**
Dr. Charles Schlagel, Director, Office of Technology Transfer, Naval Medical Research Center, 503 Robert Grant Ave, Silver Spring, MD 20910-7500, telephone (301) 319-7428, fax (301) 319-7432, or E-Mail: *[email protected].*
Dated: March 14, 2003.
R. E. Vincent II,
Lieutenant Commander, Judge Advocate General's Corps, U.S. Navy, Federal Register Liaison Officer.